Key Drivers
- Margin Recovery
- Liquidity Squeeze
- Heavy Leverage
AIAI Summary
FTRE now looks like a credible turnaround candidate rather than a broken post-spin story, with three straight quarters of >1.1x book-to-bill, a $7.846B backlog, and reaffirmed 2026 guidance signaling demand stabilization, but the investment still hinges on converting that backlog into sustained cash flow before thin margins, negative working capital, and high leverage reassert themselves.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Margin Recovery
- •Liquidity Squeeze
- •Heavy Leverage
FTRE showed modest near-term operational improvement, but persistent losses, tight liquidity, and heavy leverage still make it a high-risk turnaround.
Price Behavior
Key Price Behavior Insights:
- •Breakout hold
- •Momentum fading
- •Lower highs
FTRE's last month remains constructive after breaking above the $9–$10.5 range, but the rally has cooled with lower highs and lows, making $13.5 support and $15.6–$15.7 resistance the key near-term levels.
Sharp early-May breakout above $9–$10.5 quickly gave way to lower highs and lows
Sentiment & News
Key News Insights:
- •Earnings surprise
- •Guidance reaffirmed
- •Order momentum
Fortrea delivered a strong Q1 2026 earnings beat and reaffirmed FY2026 confidence, with a 1.15x book-to-bill ratio signaling continued demand momentum despite a cautious pre-earnings setup.
The positive earnings shock and sustained bookings trend should improve sentiment on FTRE and support the stock near term
Similar Companies in Healthcare
Other companies in the same sector with AI ratings